...
首页> 外文期刊>Health & social care in the community >Implementing an evidence-based dementia care program in the Australian health context: A cost-benefit analysis
【24h】

Implementing an evidence-based dementia care program in the Australian health context: A cost-benefit analysis

机译:在澳大利亚健康背景下实施基于证据的痴呆症课程:成本效益分析

获取原文
获取原文并翻译 | 示例
           

摘要

The World Health Organisation has called for the implementation of evidence-based interventions that enhance function and capability in people with dementia. In response, the Boosting Dementia Research Initiative in Australia has funded a number of projects aimed at improving such outcomes for people with dementia and their caregivers. What is not known is the economic and societal outcomes of these projects and of program implementation to the Australian healthcare system. The purpose of this study was to identify the costs and benefits of implementing an evidence-based reablement program within Australian health context. A well-used methodology familiar to governments and decision-makers was used to calculate the costs and benefits of implementing the program in Australia. Four different perspectives: market, private, efficiency (social) and referent group (key stakeholders) were considered in the cost-benefit evaluation. Almost A$6.2 million societal gain is presented through a social cost-benefit analysis. The referent (stakeholder) group analysis is used to demonstrate that people with dementia and their caregivers are the bearers of the costs and the Australian health and social care system gains the most from the program implementation. The results of this cost-benefit analysis suggest that there is a need to plan and provide subsidies or other financial incentives to assist people with dementia and their caregivers to engage in reablement programs in Australia; thus the whole society can be advantaged. Funding bodies and decision-makers are urged to recognise the potential societal benefits that can be achieved from participating in such reablement programs.
机译:世界卫生组织呼吁实施循证干预措施,以增强痴呆症患者的功能和能力。作为回应,澳大利亚促进痴呆症研究倡议资助了一系列项目,旨在改善痴呆症患者及其护理者的此类结果。目前尚不清楚的是这些项目的经济和社会结果,以及澳大利亚医疗体系的项目实施结果。本研究的目的是确定在澳大利亚健康背景下实施循证再修复计划的成本和收益。政府和决策者熟悉的一种常用方法被用来计算在澳大利亚实施该计划的成本和收益。成本效益评估中考虑了四个不同的角度:市场、私人、效率(社会)和参考群体(主要利益相关者)。通过社会成本效益分析,获得了近620万美元的社会收益。参考(利益相关者)群体分析用于证明痴呆症患者及其护理者是成本的承担者,澳大利亚健康和社会护理系统从项目实施中获益最大。这项成本效益分析的结果表明,有必要计划并提供补贴或其他经济激励措施,以帮助痴呆症患者及其护理者在澳大利亚参与修复项目;这样,整个社会都可以受益。我们敦促资助机构和决策者认识到参与此类重组项目可能带来的潜在社会效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号